Intertypic genomic rearrangements of poliovirus strains in vaccinees
- PMID: 2849237
Intertypic genomic rearrangements of poliovirus strains in vaccinees
Abstract
In vivo intertypic RNA recombination has previously been observed in excreted type 3 poliovirus isolates from a normal asymptomatic primary vaccinee. This study examines isolates from additional primary vaccinees to determine whether intertypic recombination is a general occurrence in excreted polioviruses. T1 RNase oligonucleotide finger-printing and limited dideoxy primer extension RNA sequencing demonstrated no evidence of intertypic recombination among type 1 or type 2 excreted strains. However, vaccinees excreting type 3 strains for long periods of time eventually produced recombinant strains involving either type 1 or type 2 poliovirus. Moreover, a characteristic time course of appearance of excreted type 3 intertypic recombinant polioviruses was established. Type 3/type 1 and type 3/type 2 recombinant strains appeared at Days 10-11 with a single crossover site in the gene for nonstructural protein 2C. Type 3/type 2/type 3 complex recombinant strains with an additional crossover site in the polymerase gene replaced type 3/type 2 strains at approximately Day 28. A significant portion of the genome of the type 3 Sabin vaccine strain is thus replaced during long-term excretion by vaccinees, and the appearance of some genomic arrangements coincided with a base deletion at the 3' terminus.
Similar articles
-
Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.J Virol. 2001 Jul;75(13):5740-51. doi: 10.1128/JVI.75.13.5740-5751.2001. J Virol. 2001. PMID: 11390576 Free PMC article.
-
[Isolation of recombinant vaccine strains of poliovirus from patients with poliomyelitis].Mol Gen Mikrobiol Virusol. 1989 Nov;(11):14-20. Mol Gen Mikrobiol Virusol. 1989. PMID: 2560812 Russian.
-
Oral poliovirus vaccine in the United States: molecular characterization of Sabin type 3 after replication in the gut of vaccinees.J Med Virol. 1991 Oct;35(2):101-9. doi: 10.1002/jmv.1890350206. J Med Virol. 1991. PMID: 1662701
-
Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.Acta Virol. 1996 Jun;40(3):157-70. Acta Virol. 1996. PMID: 8891097 Review.
-
Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.Acta Virol. 2000 Apr;44(2):109-17. Acta Virol. 2000. PMID: 10989702 Review.
Cited by
-
Evolution of 2B and 2C genomic parts of species B Coxsackie viruses. Phylogenetic study and comparison with other regions.Virus Genes. 2006 Jun;32(3):249-59. doi: 10.1007/s11262-005-6909-x. Virus Genes. 2006. PMID: 16732477
-
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.J Virol. 2000 Aug;74(16):7381-90. doi: 10.1128/jvi.74.16.7381-7390.2000. J Virol. 2000. PMID: 10906191 Free PMC article.
-
A Naturally Occurring Recombinant Enterovirus Expresses a Torovirus Deubiquitinase.J Virol. 2017 Jun 26;91(14):e00450-17. doi: 10.1128/JVI.00450-17. Print 2017 Jul 15. J Virol. 2017. PMID: 28490584 Free PMC article.
-
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.J Virol. 2005 Oct;79(20):12623-34. doi: 10.1128/JVI.79.20.12623-12634.2005. J Virol. 2005. PMID: 16188964 Free PMC article.
-
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria.J Virol. 2013 May;87(9):4907-22. doi: 10.1128/JVI.02954-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408630 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources